New research offers evidence that getting a second or third dose of the COVID-19 vaccine in the final stages of pregnancy offers protection for infants against SARS-CoV-2 infection (the virus that causes COVID-19 illness).
Co-author, Dr. Deshayne Fell helped conduct the register-based cohort study of all live-born infants in Norway born between Sept. 1, 2021 and Feb. 28, 2022. The study published in JAMA Internal Medicine is one of only two studies published that quantifies a reduction in COVID-19 infection risk in babies during the first four months of life if their mother was vaccinated during pregnancy.